Walmart shares rise 2.60% on Inspire Brands delivery partnership

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Walmart shares rose 2.60% to $108.85 on Thursday
  • New partnership with Inspire Brands integrates Dunkin' delivery into Walmart's platform
  • Q2 revenue hit $187.9 billion, up 5.9% YoY, beating estimates
  • U.S. same-store sales growth slowed to 2.6%, the lowest in six years
  • Dovish Fed comments and falling yields supported broader retail sentiment
powered bylight_fuzz_icon
50006691

*this image is generated using AI for illustrative purposes only.

Walmart Inc (NASDAQ: WMT) shares rose 2.60% to $108.85 on Thursday afternoon, buoyed by a strategic delivery expansion and favorable macroeconomic signals from the Federal Reserve.

The retail giant announced a partnership with Inspire Brands to integrate restaurant delivery services, beginning with Dunkin’ locations inside Walmart stores, directly into its digital platform.

Partnership Expands Delivery Ecosystem

The collaboration aims to leverage Walmart’s extensive store footprint and app infrastructure to broaden delivery offerings. By integrating popular restaurant brands, the company seeks to deepen customer engagement across its nationwide network.

Macro Tailwinds Support Retail

Broader market sentiment improved following dovish inflation commentary from Federal Reserve Governor Christopher Waller. U.S. Treasury yields pulled back, easing concerns about elevated interest rates and pressure on consumer discretionary spending.

Lower yields created a supportive backdrop for large-cap retail and consumer staples stocks as investors positioned for potential rate stabilization.

Post-Earnings Recovery

Thursday’s gains helped offset recent volatility following Walmart’s second-quarter earnings report released on Aug. 20. The retailer reported revenue of $187.9 billion, up 5.9% year-over-year, and adjusted EPS of $0.81, beating the $0.74 estimate.

Metric Q2 Result Change/Estimate
Revenue $187.9 billion Up 5.9% YoY
Adjusted EPS $0.81 Beat $0.74 est.
Global E-commerce N/A Up 23% YoY
Advertising Revenue N/A Up 38% YoY

Despite the top-line beat, shares had previously declined as investors focused on slowing core retail momentum. U.S. same-store sales growth dipped to 2.6%, the weakest pace in over six years.

What the Numbers Show

While global e-commerce surged 23% and advertising revenue jumped 38%, the divergence with the 2.6% same-store sales growth highlights a shift in consumer behavior. Management noted that lower- and middle-income consumers are making visible trade-offs due to persistent inflation and high fuel costs, prompting plans to reinvest tariff refunds into price reductions via more than 11,000 rollbacks.

Outlook and Guidance

Walmart raised its full-year EPS outlook to $2.80 to $2.87. However, cautious third-quarter adjusted EPS guidance of $0.62 to $0.64 reignited near-term growth concerns among investors.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the integration of Dunkin' delivery impact Walmart's customer retention rates and average order value in the coming quarters?

Will the planned price rollbacks from tariff refunds be sufficient to reverse the trend of slowing same-store sales among lower- and middle-income consumers?

Could the divergence between surging e-commerce/advertising revenue and weak same-store sales signal a long-term structural shift in Walmart's revenue mix?

like19
dislike

Walmart settles DOJ opioid lawsuit for $50 million

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Walmart settles DOJ opioid lawsuit for $50 million, admitting no wrongdoing
  • Payout termed 'immaterial' against Q2 revenue of $187.94 billion
  • Adjusted EPS of $0.81 beat analyst estimates of $0.74 by 9.46%
  • Six-month net income reached $11.79 billion ending July 31
  • Stock rose 0.45% to close at $103.09 on Friday
powered bylight_fuzz_icon
49521832

*this image is generated using AI for illustrative purposes only.

Walmart Inc. (NYSE: WMT) agreed on Friday to pay $50 million to settle a Department of Justice lawsuit alleging its pharmacies unlawfully filled opioid prescriptions.

The retailer admitted no wrongdoing and described the payout as "immaterial" in a regulatory filing. The settlement resolves allegations that Walmart violated the Controlled Substances Act since 2013 by ignoring red flags on suspicious prescriptions.

Settlement Context

The $50 million sum is a fraction of the billions in civil penalties Walmart faced when the suit was filed in December 2020. Federal prosecutors alleged that some compliance staff were aware certain prescribers operated "pill mills."

Opioids such as oxycodone and hydrocodone are used for pain treatment but have contributed to widespread addiction and overdose deaths in the U.S.

Financial Performance

Walmart reported strong financial results alongside the settlement news. For the six months ended July 31, the company posted $11.79 billion in net income.

In its second-quarter results released last week, Walmart reported revenue of $187.94 billion, slightly above the expected $186.71 billion. Adjusted earnings per share came in at $0.81, beating the analyst estimate of $0.74 by 9.46%.

Metric Reported Value Estimate/Context
Q2 Revenue $187.94 billion $186.71 billion expected
Adjusted EPS $0.81 $0.74 estimated
Net Income (6 months) $11.79 billion Ended July 31

What the Numbers Show

The $50 million settlement represents approximately 0.42% of Walmart’s reported Q2 revenue of $187.94 billion. This scale supports management’s characterization of the payout as immaterial relative to the company’s current operating scale.

Industry Landscape

Federal and state authorities have pursued opioid-related cases across the supply chain. Manufacturers like Purdue Pharma and distributors such as Cencora Inc. (NYSE: COR) have faced similar scrutiny. Retail pharmacy operators including CVS Health Corp. (NYSE: CVS) and Walgreens have reached larger settlements.

According to the Centers for Disease Control and Prevention, approximately 806,000 people died from opioid-involved overdoses between 1999 and 2023. Including provisional estimates for 2025, the cumulative total reaches approximately 905,000 deaths.

Trading Metrics

Walmart has a market capitalization of $820.4 billion. The stock closed at $103.09 on Friday, up 0.45%. Over the past 12 months, the stock has risen 7.26% but is down 8.58% year to date.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might this settlement influence the DOJ's future litigation strategy against other major retail pharmacy operators?

Will Walmart implement stricter automated compliance protocols for opioid prescriptions to mitigate future regulatory risks?

Could the precedent set by this $50 million settlement affect the valuation multiples of healthcare distributors facing similar historical liabilities?

like16
dislike

More News on Walmart